GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹17 Cr | ₹13 Cr | ₹16 Cr | ₹0.00 Cr | ₹0.17 Cr |
What is the latest Total Non-Current Liabilities ratio of GENNEX LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹17 Cr |
| Mar2024 | ₹13 Cr |
| Mar2023 | ₹16 Cr |
| Mar2022 | ₹0.00 Cr |
| Mar2021 | ₹0.17 Cr |
How is Total Non-Current Liabilities of GENNEX LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹17 Cr | 28.73 | |
| Mar2024 | ₹13 Cr | -19.60 | |
| Mar2023 | ₹16 Cr | 538,266.67 | |
| Mar2022 | ₹0.00 Cr | -98.21 | |
| Mar2021 | ₹0.17 Cr | - | |
Compare Total Non-Current Liabilities of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹284.1 Cr | -3.7% | -9.4% | -11.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,753.0 Cr | 0.9% | 6.2% | -1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,032.0 Cr | 2% | 4.8% | 4.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,426.0 Cr | 3.6% | 6% | 36.9% | Stock Analytics | |
| CIPLA | ₹108,360.0 Cr | -0.1% | -3% | -8.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,859.0 Cr | 1% | 10.8% | 4.7% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -3.7% |
-9.4% |
-11.6% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses